ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628911 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628911; 2) Community: the network communities that were significantly associated with the response to NSC 628911; 3) Molecule: the relationships between components within communities and NSC 628911; 4) MDR: the compounds that were significantly associated with the NSC 628911.

NSC Compound Enrichment Correlation
NSC 749862 3-[2-(4-methoxyphenyl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine 0.012374497233828 0.25551213
NSC 757113 METHOTREXATE(+/-) 0.012374497233828 0.4701123
NSC 112758 Rubomycin 0.0123744972338281 0.48740513
NSC 128687 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) 0.0123744972338281 0.5343702
NSC 129518 Cyclopyrethrosin 0.0123744972338281 0.41299119
NSC 179940 Benzofurazan, 4-(4-methyl-1-piperazinyl)-7-nitro-, 3-oxide 0.0123744972338281 0.55025777
NSC 328785 ANTINEOPLASTIC-328785 0.0123744972338281 0.58679474
NSC 379651 Null 0.0123744972338281 0.20658813
NSC 4280 2,9-Dimethylphenanthroline 0.0123744972338281 0.49728833
NSC 621457 Pyrimidine-2-amine, 5-chloro-6-(2-hydroxy-5-chlorophenyl)- 4-phenyl- 0.0133299224082801 -0.024219253
Total:87  Current:29    [First] [Prev] [Next] [Last]